Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Posts Smaller Q2 Revenue, Loss

NEW YORK, July 24 - Israeli bioinformatics company Compugen today reported contracted second-quarter revenue growth, thinned R&D spending and a slightly narrowed net loss.


Total revenue for the period ended June 30 was $2.8 million, down a touch from the $2.9 million Compugen posted during the same time last year. Though revenue from sales and services fell to $2.3 million from $2.8 million year over year, revenue for R&D in the current second quarter increased to $473,000 from $130,000 one year ago, the company said.


However, second-quarter R&D spending fell to $3 million from $3.8 million last year, Compugen said. This cutback likely helped the company reign in it its net loss for the second, which stood at $2.8 million, or $.11 per share, compared with $3.9 million, or $.15 per share, year over year.


Compugen said it had about $33.3 million in cash, cash equivalents, and short-term investments as of June 30.


The company has scheduled an investor conference call for 10:00 a.m. Eastern time.


Click here for more information.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.